Development code · Small Molecule
SAR442168
SAR442168 is a development code for Tolebrutinib, developed by Principia Biopharma.
- Status
- Approved for Multiple sclerosis
- Mechanism
- BTK Inhibitor
- Developer
- Principia Biopharma
Programs
- Tolebrutinib for Multiple sclerosisApprovedApproved
Also known as
- tolebrutinib
- SAR-442168
- PRN2246
- PRN-2246
- Cenrifki
- 1971920-73-6
- 4-amino-3-(4-phenoxyphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]imidazo[4,5-c]pyridin-2-one